An interventional study of Support group in Type 2 Diabetes, sponsored by Laura Staun Valentiner. Completed at 1 site in Denmark. Open to participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-10-05.
Sponsored by Laura Staun Valentiner · Not applicable, Interventional, and Treatment
Low physical fitness may cause several life style related diseases e.g. cardiovascular disease, cancer and type 2 diabetes. It is important to develop reliable methods for measurement which can be used to follow the development of the physical shape both on an individual level and on at population level.
Associated with the development of new training method known as Interval Walking we developed an application for smartphones. The use of the application InterWalk was meant to increase physical activity in patients with type 2 diabetes. The application should both be able to, 1) be a personal trainer when doing interval walking, and 2) measure the individual physical fitness performed as a walking test. The latter function was developed to make the training more personal and individal adapted, so that the training was neither too hard or too easy.
It is necessary to test the walking test against a golden standard for measuring physical fitness and that the test in the application is able to measure and register changes in physical fitness.
Our hypothesis is that the individual test, in the InterWalk Application is reliable and able to register changes in physical fitness in patients with type 2 diabetes. The purpose of this project is investigate the reliability of a smartphone-based test of physical fitness, and to investigate whether the test is able to register changes in physical fitness during the project time (3 month). A secondary aim is to investigate whether individual support during the training period, affect the individual effort and time of interval walking per week.
9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.
This study's enrollment of 37 is below the median of 80 across 7,525 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →This is the only study on the registry with Laura Staun Valentiner as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The participants in the intervention group receives the intervention and support consisting of: 1. Individual Goal Setting: 2-3 functional goals related to everyday life evaluated every 4th week. 2. SMS send every Sunday with 5 possible responses. depending on the answer of the participant it will cause a telephone call from a project about motivation and barriers for interval walking.
Other: Support group
Patient's in the control group receives the intervention with interval Walking and no other support.
The participants in the intervention group receives the intervention and support consisting of: 1. Individual Goal Setting: 2-3 functional goals related to everyday life evaluated every 4th week. 2. SMS send every Sunday with 5 possible responses. depending on the answer of the participant it will cause a telephone call from a project about motivation and barriers for interval walking.
The primary outcome is amount of time duing interval walking (in minuts) with InterWalk per week after 3 month
Time frame: up to 3 months after enrollment
Frequency of Interval walking with InterWalk
Time frame: 3 months after enrollment
Quality of data with VO2-peek test in the InterWalk Application
quantity of minuts with high and low intervals after 3 month
Time frame: 3 months after enrollment
validation of InterWalk, VO2-peek test
Time frame: 3 months after enrollment
VO2-peek test in the InterWalk Application
Time frame: 3 months after enrollment
This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.